Submit U.S. IND for LTX-315
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 6 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- October 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Submission of U.S. IND anticipated during first half of 2021”
What we found
Evidence strength A What the grades mean
The company announced an intention to submit the IND in the first half of 2021, but later filings confirm the submission occurred in October 2021, which is after the deadline.
-
A Verrica Pharmaceuticals Inc. 10-Q filed 2021-11-12
“We submitted an Investigational New Drug Application, or IND, for LTX-315 in October 2021.” ✓ confirmed on the page
Market reaction: the shares moved -5.4% against the S&P 500 over the three sessions around the disclosure (11 Nov 2021 to 16 Nov 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory filing
- Indicative materiality
- Medium rules
- Action
- Submit
- Deliverable
- U.S. IND for LTX-315
- Where
- U.S.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Verrica Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-VRCA-021129 · Corrections policy